# Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients

> **NCT07273812** · NA · NOT_YET_RECRUITING · sponsor: **Dena h. Al-Tameemi** · enrollment: 130 (estimated)

## Conditions studied

- Breast Cancer
- Breast Neoplasm
- Chemotherapy-Related Toxicities
- Medication Adherence
- Quality of Life in Cancer Patients
- Accuracy of AI App
- Symptom Management

## Interventions

- **BEHAVIORAL:** AI-Based Mobile Application for Personalized Chemotherapy Support
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT07273812
- **Lead sponsor:** Dena h. Al-Tameemi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-07
- **Final completion:** 2026-10
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- Baghdad Medical City

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07273812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07273812, "Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07273812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*